Buradasınız

Artroplastide Derin Ven Trombozu Profilaksisinde Aktif ve Erken Hareketin Etkinliği

The Effect of Active and Early Motion in the Prevention of Deep Venous Thrombosis after Arthroplasty

Journal Name:

Publication Year:

Abstract (2. Language): 
The aim of this prospective study was to compare the effectiveness of propyhlaxis with postoperative early mobilization, compressive stocking and aspirin with an another method done with low molecular weigth heparin, aspirin and compressive stockings which are more expensive than the former one. 100 patient who were planned to undergo elective total hip or knee arthroplasty were divided into two groups randomly. In group I, the propyhlaxis was done with early postoperative mobilization (2nd hour), compressive stocking and fourweek 2x300 mg aspirin. The prophylaxis in group II was mobilization in postoperative 1st day, 10 days course of low molecular weigth heparin, compressive stocking and four-week aspirin. All patients were evaluated by venography or doppler ultrasonography at postoperative 5.-7. days. The proximal thrombus was present in 2 (%4) patients, asymptomatic distal thrombus was detected in 6 patients in group I. There were 1 (%2) patient with proximal DVT, 3 (%6) patients with symptomatic distal DVT and 3 with asymptomatic distal DVT in group II (p>0.05). We conclude that prophylaxis done with postoperative 2nd hour mobilization, compressive stocking and aspirin is an effective and cheap method to prevent thromboembolic complications.
Abstract (Original Language): 
Çalışmamızda, primer total kalça ve diz artroplastisi uygulanan olgularda DVT profilaksisi için kullanılan farmakolojik ajanlardan düşük molekül ağırlıklı heparin ile mekanik olarak etki yapan ameliyat sırasında pasif hareket ve ameliyat sonrası erken dönemde mobilizasyon uygulanmasının DVT proflaksisinde etkisinin prospektif olarak karşılaştırılması amaçlandı. Bu prospektif çalışmada tek taraflı primer total kalça veya total diz artroplastisi uygulaması planlanan 100 hasta randomize olarak 2 gruba ayrıldı. Grup I’de; profilaksi için ameliyat sırasında kalça ve diz eklemine pasif hareket yaptırılıp ameliyat sonrası 2. ve 6. saatte mobilizasyon yapılırken Grup II’de ise ameliyat öncesi 12. saatte başlayıp ameliyat sonrası 10 gün devam eden düşük molekül ağırlıklı heparin uygulandı. Her iki gruba da varis çorabı ve 4 hafta süre ile 2x300 mg aspirin verildi. Her iki gruptaki hastalar ameliyat sonrası 4.-7. günlerde venografi ya da renkli doppler ultrasonografi ile değerlendirildi. Grup I’de olguların 8’inde (%16), Grup II’de ise 7’sinde (%14) DVT tespit edildi. DVT gelişimi grup I’deki olguların 2’sinde (%4) proksimal, 6’sında (%12) asemptomatik distal yerleşimli idi. Grup II’de olguların 1’inde (%2) proksimal, 3’ünde (%6) semptomatik distal DVT ve 3’ünde ise (%6) asemptomatik distal DVT saptandı (p>0.05). Sonuç olarak TKA ve TDA uygulamalarında ameliyat sırasında pasif hareket ve ameliyat sonrası erken dönemde mobilizasyonun DVT gelişimini en az düşük molekül ağırlıklı heparin kullanımı kadar engellemesi, profilaktik farmakolojik ajanların neden olabileceği yan etkileri içermemesi ve ek maliyet getirmemesi nedeni ile artroplasti ameliyatlarında DVT profilaksisi için tercih edilebilecek bir yöntem olduğu kanısındayız
127-134

REFERENCES

References: 

1. Lieberman JR, Geerts WH. Prevention of venous
thromboembolism after total hip and knee arthroplasty. J Bone
Joint Surg Am 1994; 76: 1239-50.
2. Warwick D, Williams MH, Bannister GC. Death and
thromboembolic disease after total hip replacement. J Bone
Joint Surg Br 1995; 77: 6-10.
3. Consensus development panel. Prevention of venous
thrombosis and pulmonary embolism. JAMA 1986; 256: 744-
9.
4. Johnson R, Carmichael JHE, Almond HGA, Loynes RP. Deep
venous thrombosis following Charnley arthroplasty. Clin
Orthop 1978; 132: 24-9.
5. Johnson R, Green JR, Charnley J. Pulmonary emboism and its
prophylaxis following the Charnley total hip replacement.
Clin Orthop 1977; 127: 123-7.
6. Gallus A, Raman K, Darby T. Venous thrombosis after
elective hip replacemet-the influence of preventive
intermittant calf compression and of surgical technique. Br J
Surg 1983; 70: 17-23.
7. Hull RD, Raskob GE, Gent M, McLoughlin D, Julian D,
Smith FC, Dale I, Reed-Davis R, Lofthouse RN, Anderson C.
Effectiveness of intermittant pneumatic leg compression for
preventing deep venous thrombosis after total hip replacement.
JAMA 1990; 263: 2313-9.
8. Morris GK, Henry AP, Preston BJ. Prevention of deep venous
thrombosis by low-dose heparin in patients undergoing total
hip replacement. Lancet 1974; 2: 797-801.
9. Janku GV, Paiement GD, Green HD. Prevention of venous
thromboembolism in orthopedics in The United States. Clin
Orthop 1996; 325: 313-21.
10. Fitzgerald RH, Spiro TE, Trowbridge AA, Gardner GA,
Whitsett TL, O’Connel MB, Ohar JA, Young TR. Prevention
of venous thromboembolic disease following total knee
arthroplasty. J Bone Joint Surg Am 2001; 83: 900-6.
11. Modig J, Borg T, Karlström G, Maripuu E, Sahlstedt B.
Thromboembolism after total hip replacement: role of epidural
and general anesthesia. Anesth and Analg 1983; 62: 174-80.
12. Sharrock NE, Brien WW, Salvati EA, Mineo R, Garvin K,
Sculco TP. The effect of intravenous fixed-dose heparin
during total hip arhroplasty on the incidence of deep vein
thrombosis. A randomize double blind trial in patients
operated on with epidural anesthesia and controlled
hypotension. J Bone Joint Surg Am 1990; 72: 1456-61.
13. Sharrock NE, Haas SB, Harget MJ, Urquhart B, Insall JN,
Scuderi G. Effects of epidural anesthesia on the incidence of
deep venous thrombosis after total knee arthroplasty. J Bone
Joint Surg Am 1991; 73: 502-6.
14. Altıntaş F. Kalça ve diz artroplastilerinde tromboembolizm.
Acta Orthop Traumatol Turc 2000; 34: 101-9.
15. Dahl OE, Pedersen T, Kierulf P, Westwick AB, Lund P,
Arnesen H, Seljeflot I, Abdelnoor M, Lyberg T. Sequential
intrapulmonary and systemic activation of coagulation and
fibrinolysis during and after total hip replacement surgery.
Thromb Res 1993; 70: 451-8.
16. Dahl OE, Aspelin T, Arnesen H, Seljeflot I, Kierulf P, Ruyter
R, Lyberg T. Increased activation of coagulation and
formation of late deep venous thrombosis folowing
discontinuation of thromboprophylaxis after hip replacement
surgery. Thromb Res 1995; 4: 299-306.
17. Pellegrini VD, Langhans MJ, Totterman S, Marder VJ,
Francis JW. Embolic compications of calf thrombosis
following total hip arthroplasty. J Arthroplasty 1993; 8: 449-
57.
18. Stulberg BN, Insall JN, Williams GW, Ghelman B. Deep vein
thrombosis following total knee replacement: an analysis of
638 arthroplasties. J Bone Joint Surg Am 1984; 66: 194-201.
19. Haas SB, Tribus CB, Insall JN, Becker MW, Windsor RE.
The significance of calf thrombi after total knee arthroplasty. J
Bone Joint Surg Br 1992; 74: 799-802.
20. Warwick D, Martin AG, Glew D, Bannister GC. Measurement
of femoral vein blood flow during total hip replacement.
Dublex ultrasound imaging with and without use of a foot
pump. J Bone Joint Surg Br 1994; 76: 918-21.
21. Bradley JG, Krugener GH, Jager HJ. The effectiveness of
intermittant plantar venous compression in prevention of deep
venous thrombosis after total hip atrhroplasty. J Arthroplasty
1993; 8: 57-61.
22. Comerota AJ, Katz ML, White JV. Why does prophylaxis
with externalpneumatic compression for deep vein thrombosis
fail. Am J Surg 1992; 164: 265-8.
23. DeLee JC, Rockwood CA. Current concept review. The use of
aspirin in thromboembolic diseases. J Bone Joint Surg Am
1980; 62: 149-52.
24. Haas SB, Insall JN, Scuderi GR, Windsor RE,Ghelman B.
Pneumatic sequential-compression boots compared with aspirin prophylaxis of deep vein thrombosis after total knee
arthroplasty. J Bone Joint Surg Am 1990; 72: 27-31.
25. Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M,
Huet Y. Risk of deep venous thrombosis after hospital
discharge in patients having undergone total hip replacement:
double blind, randomized comparison of enoxaparine versus
placebo. Lancet 1996; 348: 224-8.
26. Harris WH, Athanasoulis CA, Waltman AC, Salzman EW.
Prophylaxis of deep vein thrombosis after total hip
replacement. Dextran and external pneumatic compression
compared with 1.2 or 0.3 gr of aspirin daily. J Bone Joint Surg
Am 1985; 67: 57-62.
27. Leclerc JR, Gent M, Hirsh J, William HG, Ginsberg JS. The
incidence of symtomatic venous thromboembolism during and
after prophylaxis with enoxaparin. Arch Intern Med 1998;
158: 873-8.
28. Kaempffe FA, Lifeso RM, Meinking C. Intermittent
pneumatic compression versus coumadin. Prevention of deep
vein thrombosis in lower extremity total joint arthroplasty.
Clin Orthop 1991; 269: 89-97.
29. Sarmiento A, Gables C, Goswami ADK. Thromboembolic
prophylaxis with use of aspirin, exercise and graded elastic
stocking or intermittent compression devices in patients
managed with total hip arthroplasty. J Bone Joint Surg Am
1999; 81: 339-46.
30. Weitz JL. Low molecular weigth heparins. N Engl J Med
1997; 337: 688-98.
31. Bourge DL, Smith TC. Estimating allowable hemodilution.
Anesthesiology 1974; 41: 609-15.
32. Warwick D, Harrison C, Glew D, Mitchelmore A, Peters TJ,
Donovan J. Comparison of the use of foot pump with the use
of low molecular weigth heparin for the prevention of deep
vein thrombosis after total hip replacement. J Bone Joint Surg
Am 1998; 80: 1158-66.
33. Brookenthal KR, Freedman KB, Lotke PA, Fitzgerald RH,
Lonner JH. A meta analysis of thromboembolic prophylaxis in
total knee arthroplasty. J Arthroplasty 2001; 16: 293-300.
34. Francis CW, Pellegrini VD, Totterman S, Boyd AD, Marder
VJ, Liebert KM, Stulberg BN, Ayers DC, Rosenberg A,
Kessler C, Johanson NA. Prevention of deep vein thrombosis R. Şerifoğlu, ark.
134
after total hip arthroplasty. J Bone Joint Surg Am 1997; 79:
1365-72.
35. Bergqvist D, Benoni G, Björgell O, Fredin H, Headlund U,
Nicolas S, Nilsson P, Nylander G. Low molecular weigth
heparin (enoxaparin) as propyhlaxis against venous
thromboembolism after total hip replacement. N Engl J Med
1996; 335: 696-700.
36. Harris WH, Salzman EW, Athanasoulis CA, Waltman AC,
DeSanctis RW. Aspirin prophylaxis of venous
thromboembolism after total hip replacement. N Engl J Med
1977; 297: 1246-51.
37. Westermann K, Terntz O, Pretschner P, Mellmann J.
Thromboembolism after hip surgery. Int Orthop 1981; 4: 253-
60.
38. Lassen MR, Borris LC, Christiansen HM, Boll KL, Eiskjaer
SP, Nielsen BW. Prevention of thromboembolism in 190 hip
arthroplasties. Comparison of LMW heparin and placebo.
Acta Orthop Scand 1991; 62: 33-8.
39. Murray DW, Britton AR, Bulstrode CJK.
Thrombopropyhlaxis and death after total hip replacement. J
Bone Joint Surg Br 78: 1996; 863-70.
40. Hui AC, Heras-Pallou C, Dunn I, Triffitt PD, Crozier A,
Imeson J. Graded compression stocking for prevention of deep
vein thrombosis after hip and knee replacement. J Bone Joint
Surg Br 1996; 78: 550-4.
41. McCardel BR, Lachiewicz PF, Jones K. Aspirin prophylaxis
and surveillance of pulmonary embolism and deep vein
thrombosis in total hip arthroplasty. J Arthroplasty 1990; 5:
181-5.
42. Williams HR, McDonald DA. Thromboprphylaxis in lower
limb arthroplasty surgery: a review. Current Orthopedics
1997; 11: 19-23.
43. Hakki SI, Fareed J, Hoppensteadt DA, Abdullah H, Camblin J,
Nasseri AF, Hamadeh O, Wright T. Plasma tissue factor
pathway inhibitor levels as a marker for postoperative
bleeding after enoxaparin use in deep vein thrombosis
prophylaxis in orthopedics and general surgery. Clin Appl
Thromb Hemost 2001; 7: 65-71.
44. Eikelboom JW, Quinlan DJ, Douketis JD. Total kalça veya diz
replasmanı sonrasında venöz tromboemboliye karşı uzun süreli profilaksi: randomize çalışmaların bir meta-analizi. Lancet
2001; 358:9-15.
45. Boynuk B, Tözün İR, Şener N..Total kalça artroplastisinde
derin ven trombozu profilaksisi. İn: Ege r, editör.XV. milli
Türk Ortopedi ve Travmatoloji Kongre Kitabı;13-17 Eylül
1997.İstanbul-Türkiye, Ankara: THK Basımevi 1997; 724-6.
46. Paiement GD, Green HD. Thrombolic diseaseIn:Collaghan JJ,
Douglas AD, Wayne GP, Aaron GR, editors. Hip and knee
replacement patients. OKU. İllinois: American Academy of
Orthapaedic Surgeons; 1995; 1-7.
47. Westrich GH, Sculco TP. Prophylaxis against deepvenous
thrombosis after total knee arthroplasty. J Bone Joint Surg Am
1996; 78: 826-4.
48. Clarke MT, Green JS, Harper WM, Gregg PJ. Screening for
deep-venous thrombosis after hip and knee replacement
without prophylaxis.J Bone Joint Surg Br 1997, 79: 787-91.
49. Colwell CW, Spiro TE, Trowbridge AA, Morris BA, Kwaan
HC, Blaha JD. Use of enoxaparin, a low molecularweight
heparin, and unfractioned heparin for the prevention of deep
venous thrombosis after elective hip replacement. J Bone Joint
Surg Am 1994; 76: 3-14.
50. Lieberman JR, Huo MM, Hanway J, Salvati EA, Sculco TP,
Sharrock NE. The prevalance of deep venous thrombosis after
total hip arthroplasty with hypotensive epidural anesthesia. J
Bone Joint Surg Am 1994; 76: 341-8.
51. Brinker MR, Reuben JD, Mull JR, Cox DD, Daum WJ, Parker
JR. Comparison of general and epidural anesthesia in patients
undergoing primary unilateral THR. Orthopedics 1997; 20:
109-15.
52. Zimlich RH, Fulbright BM, Friedman RJ. Current status of
anticoagulation therapy after total hip and total knee
arthroplasty. J Am Acad Orthop Surg 1996; 4: 54-62.
53. Trowbridge A, Boese CK, Woodruff B, Brindley HH, Lowry
WE, Spiro TE. İncidence of posthospitalization proximal deep
venous thrombosis after total hip arthroplasty. Clin Orthop
1994; 299: 203-8.
54. Manucci PM, Citterio LE. Low-dose heparin and deep venous
thrombosis after total hip replacement. Thromb Haemost
1976; 36: 157-65.
55. Anderson DR, Gross M, Robinson KS, Petri D, Leighton R,
Stanish W, Alexander D, Mitchell M, Flemming B, Gent M.
Ultrasonographic screening for deep vein thrombosis
following arthroplasty fails to reduce posthospital
thromboembolic complications. Chest 1998; 114: 119S-22S.
56. Haas SB. The role of low molecular weigth heparins in the
prevention of venous thrombosis in surgery with special
reference to enoxoparin. Haemostasis 26 Suppl 1996; 2: 39-48.
57. Planes A, Vochelle N. The post-hospital discharge venous
thrombosis risk of the orthopedic patient. Orthopedics 20
Suppl: 1997; 18-21.

Thank you for copying data from http://www.arastirmax.com